Nuvalent Historical Balance Sheet

NUVL Stock  USD 77.96  0.32  0.41%   
Trend analysis of Nuvalent balance sheet accounts such as Total Current Liabilities of 56.7 M provides information on Nuvalent's total assets, liabilities, and equity, which is the actual value of Nuvalent to its prevalent stockholders. By breaking down trends over time using Nuvalent balance sheet statements, investors will see what precisely the company owns and what it owes to creditors or other parties at the end of each accounting year.
  
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Nuvalent. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in real.
For more information on how to buy Nuvalent Stock please use our How to buy in Nuvalent Stock guide.

About Nuvalent Balance Sheet Analysis

Balance Sheet is a snapshot of the financial position of Nuvalent at a specified time, usually calculated after every quarter, six months, or one year. Nuvalent Balance Sheet has two main parts: assets and liabilities. Liabilities are the debts or obligations of Nuvalent and are divided into current liabilities and long term liabilities. An asset, on the other hand, is anything of value that can be converted into cash and which Nuvalent currently owns. An asset can also be divided into two categories, current and non-current.

Nuvalent Balance Sheet Chart

At this time, Nuvalent's Cash is quite stable compared to the past year. Non Current Assets Total is expected to rise to about 9.8 M this year, although the value of Retained Earnings are projected to rise to (519.7 M).

Total Assets

Total assets refers to the total amount of Nuvalent assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in Nuvalent books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. The total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets.

Total Current Liabilities

Total Current Liabilities is an item on Nuvalent balance sheet that include short term debt, accounts payable, accrued salaries payable, payroll taxes payable, accrued liabilities and other debts. Total Current Liabilities of Nuvalent are important to investors because some useful performance ratios such as Current Ratio and Quick Ratio require Total Current Liabilities to be accurate. The total amount of liabilities that a company is expected to pay within one year, including debts, accounts payable, and other short-term financial obligations.
Most accounts from Nuvalent's balance sheet are interrelated and interconnected. However, analyzing balance sheet accounts one by one will only give a small insight into Nuvalent current financial condition. On the other hand, looking into the entire matrix of balance sheet accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Nuvalent. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in real.
For more information on how to buy Nuvalent Stock please use our How to buy in Nuvalent Stock guide.At this time, Nuvalent's Cash is quite stable compared to the past year. Non Current Assets Total is expected to rise to about 9.8 M this year, although the value of Retained Earnings are projected to rise to (519.7 M).
 2024 2025 (projected)
Short and Long Term Debt Total2.6M2.4M
Total Assets1.1B1.2B

Nuvalent balance sheet Correlations

0.90.970.991.00.950.64-0.76-0.990.790.750.91.00.92-0.380.991.00.821.01.01.0-0.770.880.92-0.840.9
0.90.930.920.890.780.53-0.48-0.940.530.471.00.90.92-0.040.930.910.90.890.90.9-0.710.750.94-0.760.82
0.970.930.990.970.850.49-0.61-0.990.640.60.930.970.93-0.230.970.980.910.970.970.97-0.650.760.93-0.870.84
0.990.920.990.990.90.55-0.7-1.00.720.690.920.990.94-0.290.980.990.880.990.990.99-0.710.820.94-0.860.89
1.00.890.970.990.960.64-0.77-0.990.80.760.891.00.92-0.40.991.00.811.01.01.0-0.770.890.92-0.830.91
0.950.780.850.90.960.76-0.88-0.90.90.870.780.950.81-0.540.930.940.630.960.950.95-0.840.960.83-0.680.91
0.640.530.490.550.640.76-0.75-0.570.790.750.530.640.49-0.220.630.620.40.640.640.64-0.980.810.52-0.390.64
-0.76-0.48-0.61-0.7-0.77-0.88-0.750.68-1.0-1.0-0.48-0.76-0.650.61-0.68-0.74-0.38-0.77-0.76-0.760.75-0.89-0.660.57-0.84
-0.99-0.94-0.99-1.0-0.99-0.9-0.570.68-0.72-0.67-0.94-0.99-0.950.27-0.98-0.99-0.89-0.99-0.99-0.990.72-0.83-0.950.87-0.89
0.790.530.640.720.80.90.79-1.0-0.721.00.530.790.68-0.580.720.770.420.80.790.79-0.80.920.7-0.590.87
0.750.470.60.690.760.870.75-1.0-0.671.00.470.750.65-0.610.680.730.370.760.750.75-0.750.880.66-0.570.84
0.91.00.930.920.890.780.53-0.48-0.940.530.470.90.92-0.040.930.910.90.890.90.9-0.710.750.94-0.760.82
1.00.90.970.991.00.950.64-0.76-0.990.790.750.90.92-0.380.991.00.821.01.01.0-0.770.880.92-0.840.9
0.920.920.930.940.920.810.49-0.65-0.950.680.650.920.92-0.220.890.930.840.920.920.92-0.650.80.99-0.910.9
-0.38-0.04-0.23-0.29-0.4-0.54-0.220.610.27-0.58-0.61-0.04-0.38-0.22-0.34-0.360.17-0.4-0.38-0.380.2-0.54-0.210.25-0.35
0.990.930.970.980.990.930.63-0.68-0.980.720.680.930.990.89-0.340.990.830.990.990.99-0.770.860.9-0.790.87
1.00.910.980.991.00.940.62-0.74-0.990.770.730.911.00.93-0.360.990.841.01.01.0-0.760.870.93-0.840.9
0.820.90.910.880.810.630.4-0.38-0.890.420.370.90.820.840.170.830.840.810.820.82-0.570.520.83-0.80.69
1.00.890.970.991.00.960.64-0.77-0.990.80.760.891.00.92-0.40.991.00.811.01.0-0.770.890.92-0.830.91
1.00.90.970.991.00.950.64-0.76-0.990.790.750.91.00.92-0.380.991.00.821.01.0-0.770.880.92-0.840.9
1.00.90.970.991.00.950.64-0.76-0.990.790.750.91.00.92-0.380.991.00.821.01.0-0.770.890.92-0.830.9
-0.77-0.71-0.65-0.71-0.77-0.84-0.980.750.72-0.8-0.75-0.71-0.77-0.650.2-0.77-0.76-0.57-0.77-0.77-0.77-0.88-0.680.52-0.75
0.880.750.760.820.890.960.81-0.89-0.830.920.880.750.880.8-0.540.860.870.520.890.880.89-0.880.83-0.640.91
0.920.940.930.940.920.830.52-0.66-0.950.70.660.940.920.99-0.210.90.930.830.920.920.92-0.680.83-0.830.93
-0.84-0.76-0.87-0.86-0.83-0.68-0.390.570.87-0.59-0.57-0.76-0.84-0.910.25-0.79-0.84-0.8-0.83-0.84-0.830.52-0.64-0.83-0.69
0.90.820.840.890.910.910.64-0.84-0.890.870.840.820.90.9-0.350.870.90.690.910.90.9-0.750.910.93-0.69
Click cells to compare fundamentals

Nuvalent Account Relationship Matchups

Nuvalent balance sheet Accounts

202020212022202320242025 (projected)
Total Assets10.6M293.8M482.5M732.4M1.1B1.2B
Other Current Liab3.1M5.9M12.3M22.5M48.8M51.2M
Total Current Liabilities4.4M8.8M19.5M31.8M54.0M56.7M
Total Stockholder Equity(31.3M)285.0M463.0M700.6M1.1B1.1B
Net Debt(8.1M)(68.5M)(241.8M)(335.4M)(145.7M)(153.0M)
Retained Earnings(31.9M)(78.2M)(160.1M)(286.3M)(547.1M)(519.7M)
Accounts Payable1.3M2.9M7.2M9.3M5.2M4.9M
Cash10.3M68.5M241.8M335.4M145.7M147.5M
Cash And Short Term Investments10.3M288.1M472.2M719.9M1.1B1.2B
Liabilities And Stockholders Equity10.6M293.8M482.5M732.4M1.1B1.2B
Non Current Liabilities Total37.6M2.9M7.2M0.017.9M10.9M
Other Current Assets628K5.0M5.8M6.6M14.1M14.9M
Other Stockholder Equity842K363.5M623.5M986.8M1.6B1.7B
Total Liab42.0M8.8M19.5M31.8M72.0M75.6M
Net Invested Capital(29.1M)285.0M463.0M700.6M1.1B1.1B
Total Current Assets10.6M290.6M478.0M726.5M1.1B1.2B
Accumulated Other Comprehensive Income(280.0)(228K)(494K)31K(59K)(62.0K)
Net Working Capital6.3M281.8M458.5M694.7M1.1B1.1B
Common Stock280.05K6K7K8K4.8K

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect
When determining whether Nuvalent is a strong investment it is important to analyze Nuvalent's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Nuvalent's future performance. For an informed investment choice regarding Nuvalent Stock, refer to the following important reports:
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Nuvalent. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in real.
For more information on how to buy Nuvalent Stock please use our How to buy in Nuvalent Stock guide.
You can also try the Portfolio Analyzer module to portfolio analysis module that provides access to portfolio diagnostics and optimization engine.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Nuvalent. If investors know Nuvalent will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Nuvalent listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(3.94)
Return On Assets
(0.19)
Return On Equity
(0.29)
The market value of Nuvalent is measured differently than its book value, which is the value of Nuvalent that is recorded on the company's balance sheet. Investors also form their own opinion of Nuvalent's value that differs from its market value or its book value, called intrinsic value, which is Nuvalent's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Nuvalent's market value can be influenced by many factors that don't directly affect Nuvalent's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Nuvalent's value and its price as these two are different measures arrived at by different means. Investors typically determine if Nuvalent is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Nuvalent's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.